fluoxetine has been researched along with sildenafil citrate in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Clayton, DO; Shen, WW; Urosevich, Z | 1 |
| Konner, MJ | 1 |
| Atkinson, T | 1 |
| Csoka, AB; Shipko, S | 1 |
| Archer, SL; Michelakis, ED | 1 |
| Hosseini, MM; Yarmohammadi, H | 1 |
| Brink, CB; Clapton, JD; Eagar, BE; Harvey, BH | 1 |
| Rosenzweig-Lipson, S; Schechter, LE; Sukoff Rizzo, SJ | 1 |
| Brand, L; Brink, CB; Harvey, BH; Liebenberg, N | 1 |
| Corrêa da Silva, JA; da Silva, LM; de Souza, MM; Holzmann, I; Steimbach, VM | 1 |
| Chamanara, M; Dehpour, AR; Nikoui, V; Norouzi-Javidan, A; Ostadhadi, S; Shakiba, S; Zolfaghari, S | 1 |
| Gill, SBS; Gulati, M; Jyoti, J; Kumar, B; Kumar, S; Melkani, I; Panchal, S; Pandey, NK; Singh, A; Singh, SK; Subedi, B | 1 |
| Abdel-Rafei, MK; Moustafa, EM; Rashed, ER; Thabet, NM | 1 |
2 review(s) available for fluoxetine and sildenafil citrate
| Article | Year |
|---|---|
Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors.
Topics: Adult; Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Male; Piperazines; Purines; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfones | 1999 |
An evidence-based approach to the management of pulmonary arterial hypertension.
Topics: Antihypertensive Agents; Benzamides; Bosentan; Calcium Channel Blockers; Comorbidity; Dichloroacetic Acid; Drug Therapy, Combination; Epoprostenol; Evidence-Based Medicine; Fluoxetine; Humans; Hypertension, Pulmonary; Iloprost; Imatinib Mesylate; Isoxazoles; Phosphodiesterase Inhibitors; Piperazines; Prostaglandins, Synthetic; Pulmonary Artery; Purines; Pyrimidines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Simvastatin; Sulfonamides; Sulfones; Thiophenes; Vasodilator Agents | 2006 |
1 trial(s) available for fluoxetine and sildenafil citrate
| Article | Year |
|---|---|
Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation.
Topics: Adult; Drug Therapy, Combination; Ejaculation; Fluoxetine; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sildenafil Citrate; Single-Blind Method; Sulfones; Time Factors | 2007 |
11 other study(ies) available for fluoxetine and sildenafil citrate
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
One pill makes you larger. The ethics of enhancement.
Topics: Antidepressive Agents; Consumer Product Safety; Ethics, Medical; Fluoxetine; Hormone Replacement Therapy; Human Growth Hormone; Humans; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 1999 |
Lifestyle drug market booming.
Topics: Anti-Obesity Agents; Bupropion; Drug Industry; Europe; Fluoxetine; Humans; Life Style; Marketing of Health Services; Picolinic Acids; Piperazines; Purines; Sildenafil Citrate; Sulfones; United States | 2002 |
Persistent sexual side effects after SSRI discontinuation.
Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonists; Dopamine Uptake Inhibitors; Ergolines; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Piperazines; Plants, Medicinal; Purines; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Sulfones; Testosterone; Time Factors; Treatment Outcome; Vasodilator Agents | 2006 |
Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies.
Topics: Animals; Antidepressive Agents; Atropine; Brain; Cell Line, Tumor; Fluoxetine; Humans; Male; Motor Activity; Muscarinic Antagonists; Neurons; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Receptors, Muscarinic; Signal Transduction; Sildenafil Citrate; Sulfones | 2008 |
A novel approach for predicting antidepressant-induced sexual dysfunction in rats.
Topics: Animals; Antidepressive Agents; Bupropion; Desipramine; Disease Models, Animal; Dopamine Agonists; Fluoxetine; Long-Term Care; Male; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Vasodilator Agents; Yohimbine | 2008 |
Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression.
Topics: Animals; Antidepressive Agents; Atropine; Behavior, Animal; Carbolines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Rats; Sildenafil Citrate; Sulfones; Swimming; Tadalafil | 2010 |
Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways.
Topics: Animals; Antidepressive Agents; Antioxidants; Arginine; Behavior, Animal; Disease Models, Animal; Drug Synergism; Fluoxetine; Hippocampus; Indazoles; Male; Methylene Blue; Mice; N-Methylaspartate; Olfactory Bulb; Oxidative Stress; Quercetin; Signal Transduction; Sildenafil Citrate | 2015 |
The role of nitric oxide-cGMP pathway in selegiline antidepressant-like effect in the mice forced swim test.
Topics: Animals; Antidepressive Agents; Arginine; Cyclic GMP; Drug Synergism; Fluoxetine; Guanidines; Hippocampus; Immobility Response, Tonic; Indazoles; Male; Methylene Blue; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Prefrontal Cortex; Selegiline; Signal Transduction; Sildenafil Citrate; Swimming | 2018 |
Comparison of sildenafil, fluoxetine and its co-administration against chronic constriction injury induced neuropathic pain in rats: An influential additive effect.
Topics: Analgesics; Animals; Drug Therapy, Combination; Female; Fluoxetine; Male; Neuralgia; Rats; Rats, Sprague-Dawley; Sildenafil Citrate | 2019 |
Modulation of the Nitric Oxide/BH4 Pathway Protects Against Irradiation-Induced Neuronal Damage.
Topics: Animals; Antidepressive Agents, Second-Generation; Apoptosis; Biopterins; Brain; Brain Injuries; Cranial Irradiation; Depression; Fluoxetine; Gamma Rays; Inflammation; Male; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Rats; Signal Transduction; Sildenafil Citrate; Simvastatin | 2021 |